FDA Approves Agriflu Seasonal Flu Vaccine

The U.S. Food and Drug Administration (FDA) has approved a new seasonal influenza vaccine. Agriflu can be used for the prevention of disease caused by flu virus subtypes A and B in people ages 18 and older.

Agriflu was approved using the FDA’s accelerated approval pathway after manufacturer Novartis Vaccines and Diagnostics in Siena, Italy demonstrated the vaccine’s effectiveness in preventing seasonal influenza.

Agriflu is preservative-free and available in single dose, pre-filled syringes administered intramuscularly.

The FDA announced its approval of Agriflu in a Nov. 27 press release, posted on its Web site.

Comments are closed.